Current Eye Research
SGLT2i Canagliflozin Exerts Neuroprotection in Diabetic Retinopathy by Inhibiting Microglial Proinflammatory Cytokine Release by Downregulating the TLR4/NF-κB/NLRP3 Pathway
Experiments in animalsInterventions
The paper
Guangdong Academy of Medical Sciences
Current Eye Research, 11 Aug 2026



